310-819-4871 Request Appointment Search

Cannabis fights MRSA

GreenBridge Medical Blog Cannabis fights MRSA

So, what is MRSA? It is an increasingly common and at times life threatening staph infection that is resistant to most if not all antibiotics. The most common presentation of MRSA infections are with dermatological infections.

For many, many patients this infection ruins their lives. For others it is an expensive and uncomfortable skin infection that just never goes away.

These guys, studied using various cannabinoids, including THC, CBD and CBN, for their anti-bacterial function. It turns out they have terrific staphylococcus killing power. The cannabinoids work in an unknown manner, but I am certain many more studies will be done.

Another Reference

I recently had a patient who started using a cannabis topical solution for her severe MRSA infection. She has had nearly complete remission.

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Anastasiia Chepinska
Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

virus photo
Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.